OTCMKTS:RCAR RenovaCare (RCAR) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free RCAR Stock Alerts $0.0001 0.00 (0.00%) (As of 03:01 PM ET) Add Compare Share Share Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.00▼$0.30Volume700 shsAverage Volume1,400 shsMarket Capitalization$8,735.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Get RenovaCare alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About RenovaCare Stock (OTCMKTS:RCAR)RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.Read More RCAR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RCAR Stock News HeadlinesApril 19, 2024 | cnet.comBest Midsize Car for 2022April 18, 2024 | marketwatch.comCheapest Car Insurance New JerseyApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.March 1, 2024 | benzinga.comBitcoin Laundering, 'Gucci Goddess' Army Swindle And Healthcare 'Pump And Dump' Scam: Financial Crime WeeklyOctober 12, 2023 | finance.yahoo.comRenovaCare, Inc. (RCAR) Stock Historical Prices & Data - Yahoo FinanceAugust 9, 2023 | investing.comGlobal Technology Acquisition Corp I Unit (GTACU)September 27, 2022 | reuters.comRCAR.PK - RenovaCare Inc | Stock Price & Latest News | ReutersAugust 16, 2022 | businesswire.comGlobal Burns Market Report to 2032 - Insight, Epidemiology and Forecasts - ResearchAndMarkets.com - Business WireApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.August 13, 2022 | streetinsider.comForm 10-Q RenovaCare, Inc. For: Jun 30 - StreetInsider.comMay 13, 2022 | globenewswire.comLifshitz Law PLLC Announces Investigations of CorMedix Inc. (NASDAQGM: CRMD), FirstCash Holdings, Inc. (NASDAQ: FCFS), NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), Renovacare, Inc. (OTC-BB: RCAR) - GlobeNewswireMay 4, 2022 | globenewswire.comRenovaCare Announces Termination of StemCell Systems R&D Agreement - GlobeNewswireMay 3, 2022 | finance.yahoo.comRenovaCare Announces Termination of StemCell Systems R&D Agreement - Yahoo FinanceMay 3, 2022 | finance.yahoo.comRenovaCare Announces Termination of StemCell Systems R&D AgreementApril 22, 2022 | benzinga.comGlobal Skin Burns Market Insight, Epidemiology and Market Forecast 2019-2032 Featuring Pfizer, Avita Medical, Mallinckrodt & RenovaCare - BenzingaApril 19, 2022 | businesswire.comInsights on the Global Skin Burns Market (2019 to 2032) Includes Segmentation of 7 Major Markets - ResearchAndMarkets.com - Business WireApril 14, 2022 | stockhouse.com2022-04-14 | OTCPK:RCAR | Press Release | Renovacare Inc - StockhouseApril 14, 2022 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. is Investigating RenovaCare, Inc. - Benzinga - BenzingaApril 13, 2022 | globenewswire.comLifshitz Law Firm, PC Announces Investigations of ATI Physical Therapy, Inc. (NYSE: ATIP), DraftKings Inc. (NASDAQGS: DKNG), Electric Last Mile Solutions, Inc., and Renovacare, Inc. (OTC-BB: RCAR) - GlobeNewswireMarch 25, 2022 | stockhouse.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating RenovaCare, Inc. - StockhouseMarch 24, 2022 | seekingalpha.comRenovaCare trims management team amid cost cutting measuresMarch 24, 2022 | globenewswire.comRenovaCare Announces Management Changes - GlobeNewswireMarch 24, 2022 | finance.yahoo.comRenovaCare Announces Management ChangesMarch 10, 2022 | finance.yahoo.comIris Energy Limited Announces Monthly Investor Update for February 2022 - Yahoo FinanceMarch 10, 2022 | globenewswire.comRenovaCare Provides Clinical and Corporate Update - GlobeNewswireMarch 9, 2022 | finance.yahoo.comWISeKey’s WISeID Platform Helps Individuals and Companies Reduce Cybersecurity Risks - Yahoo FinanceMarch 9, 2022 | finance.yahoo.comWorldwide Continuous Renal Replacement Therapy Industry to 2027 - Ongoing Research and Development in Continuous Renal Replacement Therapy Presents Opportunities - Yahoo FinanceSee More Headlines Receive RCAR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RenovaCare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:RCAR CUSIPN/A CIK1016708 Webwww.renovacareinc.com Phone(888) 398-0202FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares87,350,000Free Float86,601,000Market Cap$8,735.00 OptionableNot Optionable Beta1.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Harmel S. Rayat (Age 63)President, CEO, CFO, Interim Secretary & Chairman of the Board Dr. Robin A. Robinson Ph.D. (Age 68)Chairman of Scientific Advisory Board, VP & Chief Scientific Officer Comp: $220kMr. Justin Frere CPA (Age 51)M.B.A., Treasurer Comp: $208.08kDr. Jo Ellen Schweinle M.D.Chief Medical OfficerKey CompetitorsiNeedMDOTCMKTS:NEMDSafeplus InternationalOTCMKTS:ACAIMedifocusOTCMKTS:MDFZFViatar CTC SolutionsOTCMKTS:VRTTE-QureOTCMKTS:EQURView All Competitors RCAR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of RenovaCare own? Based on aggregate information from My MarketBeat watchlists, some companies that other RenovaCare investors own include Brainstorm Cell Therapeutics (BCLI), ReNeuron Group (RENE), Fulcrum Therapeutics (FULC), SCYNEXIS (SCYX), Teva Pharmaceutical Industries (TEVA), Akebia Therapeutics (AKBA), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Iovance Biotherapeutics (IOVA). How do I buy shares of RenovaCare? Shares of RCAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:RCAR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovaCare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
